INTRODUCTIONProperties of the Microgel ComplexThe Bacterial Contact Time Kill (BCT) test was used to determine the time needed for the microgel complex to demonstrate bactericidal activity against P. acne.8 This…
Read More
INTRODUCTION Since its approval by the Food and Drug Administration (FDA) in 1982, isotretinoin has been the most effective therapy for severe acne. Isotretinoin inhibits sebaceous gland function, decreases keratinization,…
Read More
CASE REPORTA 21-year-old woman of Fitzpatrick skin type V presents with a 6-month history of progressive, pruritic hypopigmented macules, without redness or scale, involving the upper and lower extremities. She…
Read More
CASE REPORT A 65 years old Caucasian man with a past medical history of degenerative disc disease (DDD), chronic neck and low back pain, asthma, food and latex allergy, constipation,…
Read More
DisclosuresAUTHOR CORRESPONDENCECrystal Agi MDCagi1@jhmi.edu
Read More
REFERENCES Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHOEORTC classification for cutaneous lymphomas. Blood . 2005 May 15 ;105(10):3768–85. Available from: http://www.ncbi. nlm.nih.gov/pubmed/15692063…
Read More
CASE REPORTAfter immigrating to the United States from El Salvador, a 16 year-old Hispanic female presented for evaluation of a long-standing eruption. She developed hypopigmented patches over her trunk and…
Read More
Galderma Receives FDA Approval of Treatment for Rosacea Galderma Laboratories, L.P. has announced that the FDA has approved Galderma’s Soolantra® (ivermectin) Cream, 1% for the once-daily topical treatment of inflammatory…
Read More
INTRODUCTION Basal cell carcinoma (BCC) is the most common cancer amongst men and women.1 The majority of non-superficial BCCs are treatable either by surgery or radiotherapy. Some BCC’s especially while…
Read More
INTRODUCTION Nearly half (48%) of nail abnormalities result from documented onychomycosis,1 with toenails affected most often (toenail-fingernail ratio: 10.6).2 In addition to its cosmetic impact, onychomycosis can be painful and…
Read More
INTRODUCTION LEF (5-methyl-N--5-methylisoxazole- 4-carboxamide) is an immuno-modulatory agent which belongs to the DMARD (Disease Modifying Anti-rheumatic Drug) class of drugs.1-4 LEF is converted to its primary metabolite “teriflunomideâ€, which inhibits…
Read More
INTRODUCTION Can modern, simple, and ubiquitous information and communication technologies (ICTs), such as smartphones and tablets, be useful conduits in physician-patient discourse? ICTs are accepted by patients and physicians for…
Read More





